T Cell Therapies for Autoimmune Indications Webinar
The immune tolerance landscape is nothing but dynamic; in our recent webinar, our expert panel discussed the obstacles in treating autoimmune diseases with T Cell therapy approaches and the strategies the developers are utilizing to overcome these obstacles. Key aspects explored included:
- A comprehensive overview of the competitive T Cell therapy within the immune-mediated disease space
- Insights into the emerging trends of Treg therapies
- A picture of what we can likely expect ahead based on recent approvals and late-stage activity
Our Experts
Rachel Hourigan
House Speaker
Lead Research Analyst
Beacon
Luka Vukoje
Moderator
Account Manager
Beacon
You May Also Be Interested In…
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
